coming soon…AATOD’s new website. Please pardon our current appearance as we transition to the new website.Read More »
Using Medication Assisted Treatment to Treat Opioid Use Disorder: Learning from Past Experience to Guide Policy
This policy paper is being released as our country continues to grapple with the challenges of the opioid use epidemic. It provides a historical context regarding the use of Medication Assisted Treatment for […]Read More »
President Trump signed the sweeping opioid legislation into law Wednesday afternoon at a White House ceremony. It was a very well attended event, including Cabinet members, legislators, leadership from our field and business leaders, especially from the large pharmacy retail groups.
Mrs. Trump also made opening remarks reflecting […]Read More »
Register Now! The 2019 American Association for the Treatment of Opioid Dependence, Inc. (AATOD) Conference will be held October 19-October 23, 2019 at Disney’s Coronado Spring Resort in Walt Disney World, FL. The 2019 conference theme, “Out of the Shadows: Managing the Opioid Epidemic through the Continuum of Care” […]Read More »
Phone Calls of Support for Medicare Part B Legislation : This is our last chance to influence the Senate/House Vote with regard to the Medicare coverage for eligible patients in OTPs. Please follow the directions in this link https://www.opioidrecovery.org/actnow/ and call your […]Read More »
Some quick FACTS about the dangers of Fentanyl:
Fentanyl has been manufactured by a number of pharmaceutical companies for the management of severe, chronic pain. There are just over one […]
We are pleased to announce the release of the End of the Year AATOD Newsletter (Special Edition). Please click HERE to view the full version of the AATOD Newsletter (PDF).
In this special issue, you will read about the following topics written by several of our Board members and […]Read More »
AATOD will produced a third and final Medicaid webinar for 2017. This webinar was designed to increase interest in utilizing Medicaid and other third-party reimbursement for OTPs. Our ultimate goal was to have every state in the United States, providing Medicaid reimbursement for Medicaid-eligible patients seeking care and being treated […]Read More »
This Fact Sheet is intended to separate anecdote and ideology from evidence and fact. AATOD hopes that this Fact Sheet will guide representatives, especially in the justice system, to better understand how federally approved medications are best used in treating opioid use disorder. We welcome all feedback. Click HERE […]Read More »
As many of our associates know, OTPs are expanding throughout the United States, responding to the increasing need to access comprehensive treatment, which is the hallmark of well-run opioid treatment programs. The AATOD Board of Directors agreed to release recommendations to the field for siting new opioid treatment programs throughout […]Read More »